Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Classifica tra le azioni
#3609
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Prezzo delle azioni
$3.74
Capitalizzazione di mercato
$4.73B
Variazione (1 giorno)
0.74%
Variazione (1 anno)
-51.90%
Paese
CN
Scambia Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categoria
Healthcare
Ricavi di Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Ricavi nel Jun 2026 TTM: $293.29M
Secondo gli ultimi rapporti finanziari di Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $293.29M. Nel 2023, l'azienda ha registrato ricavi di $778.51M una diminuzione rispetto a i ricavi dell'anno 2022, che erano pari a $1.62B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. da 2013 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $293.29M | -4.66% |
| 2024 | $307.63M | -60.49% |
| 2023 | $778.51M | -51.99% |
| 2022 | $1.62B | 79.23% |
| 2021 | $904.72M | 151.05% |
| 2020 | $360.38M | 111.99% |
| 2019 | $170.00M | 19.00% |
| 2018 | $142.86M | -2.11% |
| 2017 | $145.94M | 20.04% |
| 2016 | $121.57M | 15.98% |
| 2015 | $104.83M | 8.90% |
| 2014 | $96.26M | 17.00% |
| 2013 | $82.27M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $12.62B | 4,204.41% |
US
|
|
| $2.23B | 659.66% |
US
|
|
| $15.74B | 5,268.23% |
AU
|
|
| - | - |
CH
|
|
| $6.02B | 1,953.03% |
NL
|
